Search Results - "Cafferkey C"

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.

Authors: Gordon A Tran A Fong C et al.

Source: British journal of cancer [Br J Cancer] 2026 Jul; Vol. 135 (2), pp. 240-247. Date of Electronic Publication: 2026 Apr 21.

Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Inorganic nanoparticle-based treatment approaches for colorectal cancer: recent advancements and challenges.

Authors: Narayana, Soumya Gowda, B.H. Jaswanth Hani, Umme et al.

Source: Journal of Nanobiotechnology. 7/19/2024, Vol. 22 Issue 1, p1-25. 25p.

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for stage II–IVa esophageal cancer: a network meta-analysis.

Authors: Wang, Mingxing Dong, Wanhui Wu, Gongyi et al.

Source: Systematic Reviews. 1/27/2025, Vol. 14 Issue 1, p1-12. 12p.

Subgroup Modelling and Use of External Evidence in Precision Oncology Appraisals: An External Assessment Group Perspective on the NICE Single Technology Appraisal of Zolbetuximab for Untreated CLDN18.2-Positive HER2-Negative Unresectable Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma.

Authors: Scholte M Fernández Coves A Yang H et al.

Source: PharmacoEconomics [Pharmacoeconomics] 2026 May; Vol. 44 (5), pp. 509-513. Date of Electronic Publication: 2026 Jan 25.

Publication Type: Journal Article

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE; In Process

Consolidative thoracic radiotherapy improves the prognosis of metastatic esophageal cancer in the chemoimmunotherapy era: a propensity score matching study.

Authors: Cui, Li Yao, Nan Qin, Zhaohui et al.

Source: BMC Cancer. 11/17/2025, Vol. 25 Issue 1, p1-12. 12p.

Impact of immune checkpoint inhibitors on survival outcomes in advanced gastric cancer in Japan: A real‐world analysis.

Authors: Kadono, Toru Iwasa, Satoru Hirose, Toshiharu et al.

Source: Cancer Medicine. Jun2024, Vol. 13 Issue 12, p1-9. 9p.

Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohort.

Authors: Manfredi, Sylvain Dior, Marie Bouche, Olivier et al.

Source: Cancer Medicine. Mar2023, Vol. 12 Issue 5, p5341-5351. 11p.

An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis.

Authors: Zhang, Yaozhong Du, Huazhen Wang, Na et al.

Source: BMC Cancer. Dec2024, Vol. 24 Issue 1, p1-12. 12p.

Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study.

Authors: Turkes, Fiona Bryant, Annette Begum, Ruwaida et al.

Source: Current Oncology. Apr2022, Vol. 29 Issue 4, p2174-2184. 11p. 1 Diagram, 3 Charts, 1 Graph.

Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives.

Authors: Grizzi, Giulia Salati, Massimiliano Bonomi, Maria et al.

Source: International Journal of Molecular Sciences. Jun2023, Vol. 24 Issue 11, p9421. 15p.

Lessons (to be) learned from liquid biopsies: assessment of circulating cells and cell-free DNA in cancer and pregnancy-acquired microchimerism.

Authors: Bergmann, Lina Afflerbach, Ann-Kristin Yuan, Tingjie et al.

Source: Seminars in Immunopathology. 2/1/2025, Vol. 47 Issue 1, p1-22. 22p.

Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).

Authors: In-Ho Kim Seung Joo Kang Wonyoung Choi et al.

Source: Journal of Gastric Cancer. Jan2025, Vol. 25 Issue 1, p5-114. 110p.

A comprehensive analysis of the expression and prognostic significance of signal transducers and activators of transcription family in gastric cancer patients.

Authors: Fu, Denggang Zhang, Biyu Sun, Jinghui et al.

Source: Egyptian Journal of Medical Human Genetics. 12/23/2024, Vol. 25 Issue 1, p1-12. 12p.

Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience.

Authors: Salati, Massimiliano Ghidini, Michele Paccagnella, Matteo et al.

Source: International Journal of Molecular Sciences. Jan2023, Vol. 24 Issue 1, p813. 12p.

A Narrative Review of STAT Proteins in Diabetic Retinopathy: From Mechanisms to Therapeutic Prospects.

Authors: Hong, Libing Lin, Yongqi Yang, Xiongyi et al.

Source: Ophthalmology & Therapy. Dec2022, Vol. 11 Issue 6, p2005-2026. 22p.

Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis.

Authors: Gao, Tian-Tian Shan, Jia-Hui Yang, Yu-Xian et al.

Source: BMC Cancer. 9/17/2022, Vol. 22 Issue 1, p1-12. 12p.

Anti PD-1/Anti PDL-1 Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Meta-Analysis of Phase 2/3 Randomized Controlled Trials.

Authors: Parmar, Kanak Subramanyam, Sai Attwood, Kristopher et al.

Source: Pharmaceutics. Sep2022, Vol. 14 Issue 9, pN.PAG-N.PAG. 14p.

BP-1-102 exerts an antitumor effect on the AGS human gastric cancer cell line through modulating the STAT3 and MAPK signaling pathways.

Authors: Jiang, Xiaoxia Tang, Jian Wu, Mengjie et al.

Source: Molecular Medicine Reports. Apr2019, Vol. 19 Issue 4, p2698-2706. 9p.

Knockdown of RNF6 inhibits gastric cancer cell growth by suppressing STAT3 signaling.

Authors: Huang, Ziming Cai, Yong Yang, Chenchen et al.

Source: OncoTargets & Therapy. Oct2018, Vol. 11, p6579-6587. 9p.

The Role of Methionine Restriction in Gastric Cancer: A Summary of Mechanisms and a Discussion on Tumor Heterogeneity.

Authors: Zou, Yonghui Yuan, Yiwu Zhou, Qi et al.

Source: Biomolecules (2218-273X). Feb2024, Vol. 14 Issue 2, p161. 19p.